taxonomy (4)
protein (39)
source (7)
structure (3)
composition (1)
disease (3)
reference (11)
site (62)
peptide (63)
- Homo sapiens (Human)
- Ovis aries (Sheep)
- Columba livia (Domestic pigeon)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- Alpha-1-acid glycoprotein 1 / Homo sapiens P02763
- Alpha-1-acid glycoprotein 2 / Homo sapiens P19652
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Aminopeptidase n / Homo sapiens P15144
- Apolipoprotein d / Homo sapiens P05090
- Attractin / Homo sapiens O75882
- Biglycan / Homo sapiens P21810
- Clusterin / Homo sapiens P10909
- Coagulation factor x / Homo sapiens P00742
- Complement c1r subcomponent / Homo sapiens P00736
- Dipeptidyl peptidase 4 / Homo sapiens P27487
- Early growth response protein 3 / Homo sapiens Q06889
- Extracellular matrix protein 1 / Homo sapiens Q16610
- Golgi apparatus protein 1 / Homo sapiens Q92896
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Hepatocyte growth factor receptor / Homo sapiens P08581
- Hypoxia up-regulated protein 1 / Homo sapiens Q9Y4L1
- Inositol monophosphatase 3 / Homo sapiens Q9NX62
- Kallistatin / Homo sapiens P29622
- Keratin, type I cytoskeletal 9 / Homo sapiens P35527
- Lumican / Homo sapiens P51884
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Phosphatidylinositol-glycan-specific phospholipase D / Homo sapiens P80108
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Receptor-type tyrosine-protein phosphatase F / Homo sapiens P10586
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens Q15262
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens Q9BYF1
- Scavenger receptor cysteine-rich type 1 protein M130 / Homo sapiens Q86VB7
- Trem-like transcript 2 protein / Homo sapiens Q5T2D2
- Uromodulin / Homo sapiens P07911
- Alpha-1-acid glycoprotein / Ovis aries W5P7S6
- Ovalbumin (hi) / Columba livia
- Ovalbumin (lo) / Columba livia
- Ovomucoid / Columba livia
- Ovotransferrin / Columba livia R7VTP9
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- Egg Cell Egg White
Source
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(?1-?) + NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(a1-4)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
Reported structure
- Hex:7 HexNAc:6 NeuAc:1 (avg mass : 2663.44 )
Composition
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Unreviewed
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- N-glycan structures from the major glycoproteins of pigeon egg white: predominance of terminal Gal alpha(1)Gal. (2001 - Takahashi N, Khoo K, Suzuki N, Johnson J, Lee Y) / Status : Reviewed
- Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulfate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein. (1998 - Kuster B, Hunter A, Wheeler S, Dwek R, Harvey D) / Status : Reviewed
- Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site. (1995 - Nakagawa H, Takahashi N, Fujikawa K, Kawamura Y, Iino M, Takeya H, Ogawa H, Suzuki K) / Status : Reviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Aminopeptidase n / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Attractin / Homo sapiens
- Biglycan / Homo sapiens
- Clusterin / Homo sapiens
- Coagulation factor x / Homo sapiens
- Complement c1r subcomponent / Homo sapiens
- Dipeptidyl peptidase 4 / Homo sapiens
- Early growth response protein 3 / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Hepatocyte growth factor receptor / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Inositol monophosphatase 3 / Homo sapiens
- Kallistatin / Homo sapiens
- Keratin, type I cytoskeletal 9 / Homo sapiens
- Lumican / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Phosphatidylinositol-glycan-specific phospholipase D / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Receptor-type tyrosine-protein phosphatase F / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens
- Scavenger receptor cysteine-rich type 1 protein M130 / Homo sapiens
- Trem-like transcript 2 protein / Homo sapiens
- Uromodulin / Homo sapiens
-
Alpha-1-acid glycoprotein / Ovis aries
- Undefined site
-
Ovalbumin (hi) / Columba livia
- Undefined site
-
Ovalbumin (lo) / Columba livia
- Undefined site
-
Ovomucoid / Columba livia
- Undefined site
-
Ovotransferrin / Columba livia
- Undefined site
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- LVPVPITNATLDR (13aa)
- LVPVPITNATLDQITGK (17aa)
- WQMNFTVR (8aa)
- CIQANYSIMENGK (13aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- SVQEIQATFFYFTPNK (16aa)
- SVQEIQATFFYFTPNK (16aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- YFTPNKTEDTIFLR (14aa)
- YFTPNKTEDTIFLR (14aa)
- SGTNGTK (7aa)
- ACVCENVMDIGLTNEKPNPELSYSGSFQPAPGNK (34aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- QNQCFYNSSYLNVQR (15aa)
- QNQCFYNSSYLNVQR (15aa)
- VVNITMVALK (10aa)
- PLQEIQNLTV (10aa)
- QNQCFYNSSYINVQR (15aa)
- QDQCIYNTTYLNVQR (15aa)
- QDQCIYNTTYINVQR (15aa)
- ENDTHCIDFSYLLYSQK (17aa)
- IAVQFGPGFSWIANFTK (17aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- APGWANSSAGSGR (13aa)
- TQSLLIVNNATNVVIK (16aa)
- LHINHNNLTESVGPLPK (17aa)
- KLHINHNNLTESVGPLPK (18aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- IPNNTQWVTWSPVGHK (16aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- SWPAVGNCSSAIR (13aa)
- NYSPYYNTIDDLK (13aa)
- GNITEYQCHQYITK (14aa)
- CNYSIR (6aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- FSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPR (54aa)
- DLPQGFSALEPLVDLPIGINI (21aa)
- DFYVDENTTVR (11aa)
- VVLHPNYSQVDIGLIK (16aa)
- VVIHPNYSQVDIGIIK (16aa)
- ISHNEIADSGIPGNSFNVSSIVEIDISYNK (30aa)
- VASVININPNTTHSTGSCR (19aa)
- QVAIQTFGNQTTIIPAGGAGYK (22aa)
- MIENGSISFIPTIR (14aa)
- LNSSTIK (7aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- NLTTSLTESVDR (12aa)
- NICHLR (6aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGE (12aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- VFHIHNESWVLLTPK (15aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NATLVNEADK (10aa)
- NATIVNEADKIR (12aa)
- LSALDNLLNHSSMFLK (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- NGTHWFV (7aa)
- EELDKYFKNHTSPDVDLGDISGINA (25aa)
- KNH (3aa)
- NETHNPTVK (9aa)
- MLWEHNSTIIVMLTK (15aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 2663.44)
- Blood Serum (UBERON_0001977)
-
Alpha-1-acid glycoprotein 2 / Homo sapiens
- Undefined site
-
Alpha-1-acid glycoprotein / Ovis aries
- Undefined site
-
- N-Linked / Complex (avg mass : 2663.44)
- Blood Plasma (UBERON_0001969)
- Coagulation factor x / Homo sapiens
-
- N-Linked / Complex (avg mass : 2663.44)
-
Ovalbumin (hi) / Columba livia
- Undefined site
-
Ovalbumin (lo) / Columba livia
- Undefined site
-
Ovomucoid / Columba livia
- Undefined site
-
Ovotransferrin / Columba livia
- Undefined site
-
- Hex:7 HexNAc:6 NeuAc:1 / N-Linked (avg mass : 2663.44)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(?1-?) + NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Aminopeptidase n / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Attractin / Homo sapiens
- Biglycan / Homo sapiens
- Clusterin / Homo sapiens
- Complement c1r subcomponent / Homo sapiens
- Dipeptidyl peptidase 4 / Homo sapiens
- Early growth response protein 3 / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Hepatocyte growth factor receptor / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Inositol monophosphatase 3 / Homo sapiens
- Kallistatin / Homo sapiens
- Keratin, type I cytoskeletal 9 / Homo sapiens
- Lumican / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Phosphatidylinositol-glycan-specific phospholipase D / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Receptor-type tyrosine-protein phosphatase F / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens
- Scavenger receptor cysteine-rich type 1 protein M130 / Homo sapiens
- Trem-like transcript 2 protein / Homo sapiens
- Uromodulin / Homo sapiens
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- LVPVPITNATLDR (13aa)
- LVPVPITNATLDQITGK (17aa)
- WQMNFTVR (8aa)
- CIQANYSIMENGK (13aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- SVQEIQATFFYFTPNK (16aa)
- SVQEIQATFFYFTPNK (16aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- YFTPNKTEDTIFLR (14aa)
- YFTPNKTEDTIFLR (14aa)
- SGTNGTK (7aa)
- ACVCENVMDIGLTNEKPNPELSYSGSFQPAPGNK (34aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- QNQCFYNSSYLNVQR (15aa)
- QNQCFYNSSYLNVQR (15aa)
- VVNITMVALK (10aa)
- PLQEIQNLTV (10aa)
- QNQCFYNSSYINVQR (15aa)
- QDQCIYNTTYLNVQR (15aa)
- QDQCIYNTTYINVQR (15aa)
- ENDTHCIDFSYLLYSQK (17aa)
- IAVQFGPGFSWIANFTK (17aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- APGWANSSAGSGR (13aa)
- TQSLLIVNNATNVVIK (16aa)
- LHINHNNLTESVGPLPK (17aa)
- KLHINHNNLTESVGPLPK (18aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- IPNNTQWVTWSPVGHK (16aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- SWPAVGNCSSAIR (13aa)
- NYSPYYNTIDDLK (13aa)
- GNITEYQCHQYITK (14aa)
- CNYSIR (6aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- FSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPR (54aa)
- DLPQGFSALEPLVDLPIGINI (21aa)
- DFYVDENTTVR (11aa)
- VVLHPNYSQVDIGLIK (16aa)
- VVIHPNYSQVDIGIIK (16aa)
- ISHNEIADSGIPGNSFNVSSIVEIDISYNK (30aa)
- VASVININPNTTHSTGSCR (19aa)
- QVAIQTFGNQTTIIPAGGAGYK (22aa)
- MIENGSISFIPTIR (14aa)
- LNSSTIK (7aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- NLTTSLTESVDR (12aa)
- NICHLR (6aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGE (12aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- VFHIHNESWVLLTPK (15aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NATLVNEADK (10aa)
- NATIVNEADKIR (12aa)
- LSALDNLLNHSSMFLK (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- NGTHWFV (7aa)
- EELDKYFKNHTSPDVDLGDISGINA (25aa)
- KNH (3aa)
- NETHNPTVK (9aa)
- MLWEHNSTIIVMLTK (15aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
